Business UpdateJun 5, 2026, 09:02 AM
TOMI Sees Accelerating Demand for SteraMist Amid Rising Disease Threats
AI Summary
TOMI Environmental Solutions reports accelerating demand for its SteraMist ionized Hydrogen Peroxide (iHP) technology due to a sharp increase in infectious disease alerts, including norovirus and Ebola. National public health data indicates sustained norovirus concentrations, highlighting the need for scalable biosecurity solutions. SteraMist, originally developed with U.S. Department of Defense support, offers validated, automated efficacy for contamination control across critical sectors like healthcare, hospitality, and transportation. The company anticipates leading a multi-year expansion in global environmental decontamination spending as institutions adopt ongoing preparedness strategies.
Key Highlights
- TOMI reports accelerating demand for SteraMist iHP technology due to increased infectious disease alerts.
- National public health data shows sustained norovirus concentrations prolonging winter peaks into late spring.
- SteraMist offers validated, automated efficacy for norovirus contamination control in high-density environments.
- Technology is critical for hospitals, hotels, cruise lines, schools, airports, and government agencies.
- SteraMist was originally developed with support from the U.S. Department of Defense.
- CEO Dr. Halden Shane emphasizes the need for automated, high-level disinfection technology.
- Industry is entering a major, long-term demand cycle for advanced infection-control technologies.
- TOMI is positioned to lead a multi-year expansion in global environmental decontamination spending.
Price Impact
More from TOMZ